HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Monath, T. P. Articles by Prange, W. C. Search for Related Content PubMed PubMed Citation Articles by Monath, T. P. Articles by Prange, W. C.

Yellow Fever Monoclonal Antibodies: Type-Specific and Cross-Reactive Determinants Identified by Immunofluorescence^*

T. P. Monath, J. J. Schlesinger, M. W. Brandriss, C. B. Cropp AND W. C. Prange

Division of Vector-Borne Viral Diseases, Center for Infectious Diseases, Centers for Disease Control, Public Health Service, U.S. Department of Health and Human Services, Fort Collins, Colorado 80522
Department of Medicine, Rochester General Hospital, University of Rochester School of Medicine and Dentistry, 1425 Portland Avenue, Rochester, New York 14621

Monoclonal antibodies directed against the envelope glycoprotein and the NV3 non-structural viral protein of yellow fever (YF) were tested by the indirect fluorescent antibody technique against a variety of YF virus strains and heterologous flaviviruses. Monoclonal antibodies directed against the envelope glycoprotein exhibited YF strain-specificity, YF type-specificity, broad group cross-reactivity, or limited subgroup reactivity (YF + Banzi or YF + Koutango + Zika + Usutu + Uganda S). Monoclonal antibodies directed against NV3 reacted either with YF + Koutango or with YF + Banzi. These findings generally correlated with the results of biological tests reported previously. Monoclonal antibodies that were type-specific to YF will be useful for the rapid specific identification of YF virus isolates and are available from the Centers for Disease Control on request.

Accepted for publication January 20, 1984.

^* Address reprint requests to: Thomas P. Monath, M.D., Division of Vector-Borne Viral Diseases, Center for Infectious Diseases, Centers for Disease Control, Post Office Box 2087, Fort Collins, Colorado 80522.